Cell Therapy Market to Soar from $4.17B in 2023 to $42.44B by 2031 - Most Leading Companies are Gilead Sciences, Inc., Novartis, AG, Vericel Corporation

Cell Therapy Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

The global cell therapy market reached US$ 4.17 billion in 2023 and is expected to reach US$ 42.44 billion by 2031, growing at a CAGR of 30.67% during the forecast period 2024-2031.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/cell-therapy-market?rk

Cell therapy involves the transplantation of cells into a patient to treat diseases or injuries. It includes therapies like stem cell therapy, where stem cells are used to repair damaged tissue. Cell therapy has shown promise in treating conditions such as cardiovascular diseases, autoimmune disorders, and neurodegenerative diseases. The therapy works by replacing damaged or diseased cells with healthy ones to restore function. Regulatory advancements are helping to make cell therapy more accessible to patients.

Cell Therapy Market Recent Development:

In August 2024, The Food and Drug Administration (FDA) has approved a cellular therapy known as afamitresgene autoleucel, or afami-cel (Tecelra), to treat individuals with metastatic synovial sarcoma, a type of soft tissue sarcoma. This is the first time the agency has approved a T-cell receptor (TCR) therapy for cancer.

List of the Key Players in the Cell Therapy Market:

Gilead Sciences, Inc., Novartis, AG, Vericel Corporation, CO.DON GmbH, Bristol Myers Squibb Company, IOVANCE Biotherapeutics, Inc., Dendreon Pharmaceuticals LLC, Enzyvant Therapeutics GmbH, CellTrans, Gamida Cell Inc.

Assessing the Effects of U.S. Tariffs on the Cell Therapy Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Cell Therapy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/cell-therapy-market?rk

Segment Covered in the Cell Therapy Market:

By Delivery Technology: Non Viral Delivery, Physical Methods, Chemical Methods, Viral Delivery.

By Cell Type: Stem Cell, Non-Stem Cell.

By Therapy Type: Autologous Therapy, Allogeneic Therapy.

By Application: Cancer, Autoimmune Disorders, Musculoskeletal Disorders, Dermatology, Others.

By End User: Hospitals, Specialty Clinics, Others.

Regional Analysis for Cell Therapy Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Cell Therapy Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Cell Therapy market?

➠ Who are the top manufacturers in the global Cell Therapy industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Cell Therapy market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Cell Therapy market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Cell Therapy industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/cell-therapy-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.